Suchergebnisse - "Magro, Giuseppe"

PubPharm (68)

11

Characterization of a flat-panel detector for 2D dosimetry in scanned proton and carbon ion beams

enthalten in: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) | 2023

von Rossi, E. | Russo, S. | Maestri, D. | +8

12

In Vitro Effects of Photon Beam and Carbon Ion Radiotherapy on the Perineural Invasion of Two Cell Lines of Neurotropic Tumours

enthalten in: Life (Basel, Switzerland) | 2023

von Charalampopoulou, A. | Barcellini, A. | Frittitta, G. | +8

13

Natalizumab wearing-off symptoms : effect of extend interval dosing during Sars-CoV-2 pandemic

enthalten in: Journal of neurology | 2023

von Magro, G. | Barone, S. | Tosto, F. | +8

14

A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy

enthalten in: Cancers | 2022

von Morelli, L. | Parrella, G. | Molinelli, S. | +9

15

There is an urgent need to standardize sonothrombolysis!

enthalten in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences | 2022

von Magro, G. | Tosto, F.

16

Dosimetric validation of a GPU-based dose engine for a fast in silico patient-specific quality assurance program in light ion beam therapy

enthalten in: Medical physics | 2022

von Magro, G. | Fassi, M. | Mirandola, A. | +8

17

Corrigendum to "Olamkicept(sgp130Fc) : The missing trial in Neuromyelitis Optica Spectrum Disorder" [Clinical Immunology 241 (2022) 109072

enthalten in: Clinical immunology (Orlando, Fla.) | 2022

von Magro, G.

ErratumFor: Clin Immunol. 2022 Aug;241:109072. - PMID 35798242

18

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic

enthalten in: Journal of neurology | 2022

von Magro, G. | Barone, S. | Tosto, F. | +8

19

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic

enthalten in: Journal of neurology | 2022

von Magro, G. | Barone, S. | Tosto, F. | +8

20

Satralizumab might not be enough. Olamkicept (sgp130Fc) in Neuromyelitis Optica Spectrum Disorder

enthalten in: Multiple sclerosis and related disorders | 2022

von Magro, G.